Wordt geladen...
MAPK pathway activity plays a key role in PD‐L1 expression of lung adenocarcinoma cells
Immune checkpoint inhibitors targeting programmed cell death protein 1 (PD‐1) and programmed death‐ligand 1 (PD‐L1) have improved the survival of patients with non‐small cell lung cancer (NSCLC). Still, many patients do not respond to these inhibitors. PD‐L1 (CD274) expression, one of the factors th...
Bewaard in:
| Gepubliceerd in: | J Pathol |
|---|---|
| Hoofdauteurs: | , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
John Wiley & Sons, Ltd
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6767771/ https://ncbi.nlm.nih.gov/pubmed/30972766 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/path.5280 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|